The “initial rescissions” order, signed in front of cheering crowds at the Capital One Arena, revokes dozens of Biden administration policies that the new White House called inflammatory ...
The memo, sent by acting Homeland Security Secretary Benjamine Huffman, says DHS is granting immigration-enforcement authority to several agencies at the Justice Department, including the Drug ...
(Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) and the European Medicines Agency (EMA) has ...
GLP-1RA drugs like Ozempic offer significant health benefits, including weight loss, improved brain health, and reduced addiction risks, but also pose risks like pancreatitis and kidney issues.
President Trump pardoned Ross Ulbricht, the founder of notorious 2010s drug trafficking website Silk ... the Federal Courthouse on May 29, 2015 in New York. (DON EMMERT/AFP via Getty Images ...
President Donald Trump’s proposal to rename the Gulf of Mexico to the “Gulf of America” exemplifies a focus on symbolic gestures rather than addressing significant global challenges.
PHILADELPHIA (WPVI) -- The City of Philadelphia is launching a new program in the Kensington neighborhood on Wednesday, with the goal of sending those with drug addictions to treatment rather than ...
"We're hopeful this will mean we can find some much-needed new treatments for dementia and speed up the process of getting them to patients," says Underwood. "If we can find drugs that are already ...
The younger Maltz later headed the New York Drug Enforcement Task Force, the oldest and largest drug task force in America. Maltz also helped develop and implement an effort by the departments of ...
A comprehensive new study confirmed that GLP-1 medications ... researchers at the Department of Veterans Affairs found that GLP-1 weight-loss drugs have an impact on a whopping 175 diseases ...
This could lead to faster drug development, cheaper costs, and new cures. Yet discovering the drugs is merely one step in the process. it’s only when big pharma decides they’re worth ...
As for Alzheimer’s and other neurocognitive disorders, the research showed that use of the new diabetes and obesity drugs reduced the risk by 12%, but Al-Aly said the figure is likely larger ...